Search clinical trials for: Dysthyroid Ophthalmopathy

Total 160 results

Viridian Therapeutics, Inc.

Recruiting

A Randomized, Double-masked, Placebo-controlled Safety, Tolerability, and Efficacy Study of VRDN-001, a Humanized Monoclonal Antibody Directed Against the IGF-1 Receptor, in Participants With Chronic Thyroid Eye Disease (TED)

Thyroid Eye Disease

United States, Turkey
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Customized Multiple Orbital Wall Decompression for Sight-threatening Graves's Ophthalmopathy

Thyroid Eye Disease

China
Viridian Therapeutics, Inc.

Recruiting

A Safety, Tolerability and Efficacy Study of VRDN 001 in Healthy Volunteers and Persons With Thyroid Eye Disease (TED)

Thyroid Eye Disease

Spain, United States, Netherlands, Germany, Canada, United Kingdom, Italy, Australia, France, Turkey
Fondation Ophtalmologique Adolphe de Rothschild

Completed

mDixon TSE MRI Sequence And Conventional MRI Sequences In Dysimmune Orbitopathies (DDX) (DDX)

Dysthyroid Ophthalmopathies

France
Sun Yat-sen University

Unknown

The Therapeutic Effect of Dysthyroid Optic Neuropathy

Thyroid Eye Disease

China
Medical University of Warsaw

Completed

Liver Function After Intravenous Methylprednisolone Administration

Liver Diseases | Liver Failure | Graves Ophthalmopathy | Graves Disease | Acute Liver Failure | Acute Liver Injury | Liver Dysfunction | Glucocorticoids Toxicity | Liver Injury | Liver Insufficiency | Acute Liver Injury, Drug Induced | Methylprednisolone Adverse Reaction | Dysthyroid Orbitopathy | Dysthyroid Ophthalmopathy
University of Sao Paulo

Completed

Morphometric Analysis of Orbital Structures in Graves´ Orbitopathy

Dysthyroid Orbitopathy

Brazil
Silkiss, Rona Z., M.D., FACS
Lauer, Simeon, M.D.; Reier, Alice M.D.; Coleman, Morton M.D.

Completed

Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy

Thyroid Related Orbitopathy | Graves' Dysthyroid Ophthalmopathy

United States
Janjira Petsuksiri
Mahidol University

Not yet recruiting

Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)

Thyroid Associated Ophthalmopathy

Thailand
Viridian Therapeutics, Inc.

Not yet recruiting

A Randomized, Active Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

Thyroid Eye Disease

United States
Medical University of Warsaw

Recruiting

Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease)

Thyroid Eye Disease | Ophthalmopathy | Orbitopathy, Graves

Poland
Peking University Third Hospital

Recruiting

Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease

Thyroid Eye Disease

China
argenx

Recruiting

A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease

Thyroid Eye Disease

United States
argenx

Recruiting

A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease.

Thyroid Eye Disease

United States
Cairo University

Recruiting

Comparison Between Peribulbar And Sub-tenon Blocks on Oculocardiac Reflex (OCR) During Pediatric Strabismus Surgery

Anesthesia, Local | Strabismus | Pediatric ALL | Ophthalmopathy

Egypt
Walter Reed National Military Medical Center

Recruiting

The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction (Teprotumumab)

Thyroid Eye Disease | Graves Ophthalmopathy | Graves Disease

United States
Amgen

Recruiting

A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease

Thyroid Eye Disease

United States
Assiut University

Not yet recruiting

Evaluation of the Corneal Endothelial Cell Layer by Specular Microscopy in Patients With Thyroid Eye Disease

Thyroid Eye Disease
Lassen Therapeutics Inc.

Recruiting

A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

Eye Diseases | Endocrine System Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis

United States, United Kingdom, Spain
Viridian Therapeutics, Inc.

Recruiting

An Open-label Study for Participants Who Are Non-responders at the End of Treatment Assessment on the VRDN-001-101 and VRDN-001-301 Pivotal Studies

Thyroid Eye Disease

United States
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Multicenter, Open-label Extension Study Evaluating the Efficacy and Safety of IBI311 in Subjects With Thyroid Eye Disease

Thyroid Eye Disease, TED

China
Sling Therapeutics, Inc.

Recruiting

A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Eye Diseases | Endocrine System Diseases | Thyroid Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Exophthalmos | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis | IGF1R | Hashimoto

United States
Hoffmann-La Roche

Recruiting

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Participants With Thyroid Eye Disease (SatraGO-2) (SatraGO-2)

Thyroid Eye Disease

Korea, Republic of, United States, United Kingdom, China, Canada, France, Spain
Sohag University

Recruiting

Effect Of Reusing the Operative Supplies On Cataract Surgery and Climate Change

Ophthalmopathy

Egypt
Tourmaline Bio, Inc.

Recruiting

A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 75 Years of Age With Thyroid Eye Disease (spiriTED)

Thyroid Eye Disease

United States, Jordan
Hoffmann-La Roche

Recruiting

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Participants With Thyroid Eye Disease

Thyroid Eye Disease | TED

Japan, Australia, United States, Argentina, Germany, Italy
ACELYRIN Inc.

Recruiting

Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED) (TED)

Thyroid Eye Disease

United States, Australia
Vastra Gotaland Region

Recruiting

Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease

Autoimmune Diseases | Thyroid Diseases | Mental Fatigue | Graves Ophthalmopathy | Graves Disease

Sweden
First Affiliated Hospital Xi'an Jiaotong University
Nanjing First Hospital, Nanjing Medical University; Beijing Tongren Hospital; People's Hospital of Xinjiang Uygur Autonomous Region and other collaborators

Not yet recruiting

Rapamycin Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-severe Graves' Orbitopathy.

Graves Ophthalmopathy

China
Immunovant Sciences GmbH

Recruiting

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

Thyroid Eye Disease

United States, Belgium, Latvia, Hungary, Spain, Slovakia, Puerto Rico, New Zealand, Turkey
Immunovant Sciences GmbH

Recruiting

Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease

Thyroid Eye Disease

United States, Hungary, Spain, Latvia, Belgium
Immunovant Sciences GmbH

Recruiting

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

Thyroid Eye Disease

United States, Italy, Poland, United Kingdom, Canada, Israel, Germany, Japan
Vanderbilt University Medical Center

Recruiting

Assessment of the Ocular Microbiome in Health and Disease

Eye Diseases | Microbial Colonization | Ophthalmopathy

United States
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Not yet recruiting

Efficacy and Safety of SHR-1314 by Subcutaneous Injection in Active Moderate to Severe Graves' Orbitopathy Patients

Active Moderate to Severe Graves' Orbitopathy
Lassen Therapeutics 1 PTY LTD

Recruiting

A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease

Thyroid Eye Disease | Pulmonary Fibrosis

Australia, New Zealand, Hong Kong
Sling Therapeutics, Inc.

Recruiting

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) (LIDS)

Eye Diseases | Endocrine System Diseases | Thyroid Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Exophthalmos | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis | IGF1R | Hashimoto

United States, Spain, Canada, Italy, United Kingdom
Medical University of Silesia

Recruiting

Antithymocyte Globulin as a Second Line Therapy in Graves Orbitopathy

Graves Orbitopathy

Poland
National Taiwan University Hospital

Recruiting

Hydroxychloroquine in Mild Graves' Orbitopathy

Graves Ophthalmopathy

Taiwan
Sun Yat-sen University

Recruiting

Multi-model Image of Doxycycline in TAO

Thyroid Associated Ophthalmopathy

China
Sun Yat-sen University

Recruiting

Multi-model Image of Immunosuppressive Agents in TAO

Thyroid Associated Ophthalmopathy

China
University of Pisa
University of Messina; University of Catania; Università degli Studi dell'Insubria

Not yet recruiting

A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study (STAGO-2)

Graves' Orbitopathy

Italy
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease

Thyroid Ophthalmopathy

China
Imperial College London

Recruiting

Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting (EHD-Pred PK)

Vasculitis | Asthma | Thyroid Eye Disease | Inflammatory Disease | COPD Exacerbation Acute

United Kingdom
Haukeland University Hospital

Recruiting

Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease

Thyroid-Associated Ophthalmopathy

Norway
Sun Yat-sen University

Not yet recruiting

Supramaximal Rectus Recession for Strabismus in Grave's Ophthalmopathy

Graves Ophthalmopathy | Strabismus, Mechanical
Sun Yat-sen University

Not yet recruiting

Combination of Orbital Compression Surgery and Strabismus Surgery for Thyroid Associated Ophthalmopathy

Thyroid Associated Ophthalmopathy

China
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...
Azienda Ospedaliero, Universitaria Pisana; Istituto Auxologico Italiano; Azienda... and other collaborators

Recruiting

Tocilizumab in Active Moderate-severe Graves' Orbitopathy (TOGO)

Graves Ophthalmopathy

Italy
University of Pisa

Recruiting

A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy (ABLAGO)

Graves' Orbitopathy

Italy
University of Zurich

Recruiting

Exophthalmometry With 3D Face Scanners (EX3D)

Graves Ophthalmopathy | Exophthalmos | Orbital Fractures | Orbital Tumor

Switzerland
Althaia Xarxa Assistencial Universitària de Manresa
Societat Catalana d'Oftalmologia

Recruiting

Evaluation of the Efficacy and Safety of 3D Printing for Orbital Surgery.

Surgical Procedure, Unspecified | Thyroid Associated Ophthalmopathy

Spain

Search clinical trials for: Dysthyroid Ophthalmopathy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations